Gliclazide (Comparison drug)

WITHDRAWN · PHASE4 · Angina Pectoris, Diabetes Mellitus, Type 2

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.